Takeda UK boosts senior leadership team

13 November 2015

The UK division of Japanese pharma company Takeda (TYO: 4502) has boosted its senior leadership team in a bid to drive forward its expertise in the specialty care sector.

Simon Meadowcroft (pictured above right) has joined the company as its new medical director, whilst Pauline Bromley (pictured above left) has been brought in as human resources director.

Commenting on the new appointments, Adam Zaeske, managing director, said: “Takeda is committed to advancing healthcare by developing specialist medicines that meet the needs of patients, healthcare professionals and society. The recruitment of these two new senior roles will ensure that we are perfectly positioned to deliver on our aspirations.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK